Clinical significance of interferon lambda-3 (IFNλ3)/interleukin 28B (IL28B) in systemic lupus erythematosus patients

Background: Inappropriate and excessive activation of type I interferon (IFN) system is a key feature of systemic lupus erythematosus (SLE), and its targeting has led to important achievements in the development of novel drugs for SLE. Aim of the work: To evaluate the serum levels of interferon lamb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fatma H. Abdelraouf, Manal E.S. Ramadan, Dina O. Abdulazim, AliGenena, Heba M. Selim
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/1b7854bf86d5419fa149cc68dd2fb747
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!